Potential lupus drug gets FDA priority review - BusinessWeek

[INCIID News Feed]

<img alt="" height="1" width="1" />
Potential lupus drug gets FDA priority review
BusinessWeek
Regulators should reach a decision by early December on an experimental lupus drug made by Human Genome Sciences and GlaxoSmithKline, the companies said Thursday. The Food and Drug Administration is conducting a priority review of Benlysta as a ...
Glaxo, Human Genome get fast review for lupus drugReuters
FDA To Do Priority Review Of Human Genome, Glaxo Lupus DrugWall Street Journal
Benlysta, BMS melanoma drug win accelerated FDA reviewFierceBiotech
RTT News -Drug Store News -Schaeffers Research (blog)
all 107 news articles &raquo;


More...